Editorial Commentary
Zongertinib and the next chapter of human epidermal growth factor receptor 2-targeted therapy in non-small-cell lung cancer
Shanghai Chest
2026;
10:
13
.
(30 April 2026)
Editorial Commentary
Lurbinectedin plus atezolizumab maintenance in extensive-stage small-cell lung cancer: breaking the four-decade stalemate or exposing the limits of incremental progress?
Shanghai Chest
2026;
10:
12
.
(30 April 2026)
Editorial Commentary
Locoregional relapse after segmentectomy: interpreting JCOG0802 in the context of modern practice
Shanghai Chest
2026;
10:
11
.
(30 April 2026)
Editorial Commentary
Revisiting consolidation immunotherapy: the promise of COAST after PACIFIC
Shanghai Chest
2026;
10:
10
.
(30 April 2026)
Editorial Commentary
Datopotamab deruxtecan in EGFR-mutated lung cancer: an exciting new option
Shanghai Chest
2026;
10:
9
.
(30 April 2026)
Editorial Commentary
Avoiding locoregional relapse after segmentectomy: radiologic aggressiveness, margin discipline, and technical precision
Shanghai Chest
2026;
10:
8
.
(30 April 2026)
Editorial Commentary
Positioning of erlotinib plus ramucirumab therapy in current clinical practice for EGFR-mutated non-small cell lung cancer
Shanghai Chest
2026;
10:
7
.
(30 April 2026)
Case Report
Intrathoracic migration of a Kirschner wire in a patient with osteoporosis: a case report
Shanghai Chest
2026;
10:
6
.
(30 April 2026)
Case Report
Perimammary uniportal video-assisted thoracoscopic surgery rib resection with posterior accessory disarticulation of a large bone hemangioma: a case report
Shanghai Chest
2026;
10:
5
.
(30 April 2026)
Original Article
Beat Work Index, Cardiac Power Index, and Arterial Elastance Index: a novel non-invasive approach to assessing hemodynamic status in children following cardiovascular surgery
Shanghai Chest
2026;
10:
4
.
(30 April 2026)